STAT+: KRAS, the ideal cancer drug target that became ‘undruggable,’ takes on a new glow

“This is the saga of the pharmaceutical industry. One or two drugs are approved in a given indication, target, or class, and this fuels the level of enthusiasm among others…
Click here to view original post


ADVERTISEMENT — Advertise With Biotech Networks